#drug design — Wednesday, April 01, 2026 (2 items)
| 0 | ℹ |
CSN5i-3 is an orthosteric molecular glue inhibitor of COP9 signalosome.
(nature.com)
|
Nature 2026-04-01 | #proteomics #ubiquitination #drug design #inhibition #molecular-glue | |
| 0 | ℹ |
Designing novel bisquinoline antimalarials from historical 4-aminoquinolines to combat drug-resistant malaria.
(journals.asm.org)
|
Antimicrobial Agents and Chemotherapy 2026-04-01 | #pharmacokinetics #amr #antimalarial #drug design #structure-activity |